NEWS FLASH

Outlook for the year 2008

Unaudited financial results for the quarter ended 30th June, 2006
 
 
Financials
Ind-Swift Laboratories Limited
UNAUDITED FINANCIAL RESULTS (PROVISIONAL) FOR THE QUARTER ENDED 31ST DECEMBER, 2002
(RS. IN LACS)
PARTICULARS
3 Months 31.12.2002
QNAUDITED
3 Months 31.12.2001
UNAUDITED
9 Months 31.12.2002
UNAUDITED
9 Months 31.12.2001
UNAUDITED
Year Ending 31.03.2002
AUDITED
 Net Sales/Operational Income
4101.19
3068.99
10395.23
8074.46
11280.92
 Others Income
13.15
19.42
33.91
47.96
40.08
 TOTAL EXPENDITURE :
3708.29
2734.37
9262.41
7129.79
9911.24
 (a) Increase/decrease in stock in trade
225.71
139.39
520.28
208.71
73.77
 (b) Consumption of Raw Material
3516.80
2526.16
8565.65
6398.34
8638.82
 (c) Staff Cost
51.15
58.29
146.76
136.83
192.60
 (d) Other expenditure
366.06
289.31
1070.28
803.34
1153.59
 Interest
158.82
135.80
480.89
401.59
617.69
 Depreciation
58.30
49.06
169.77
135.71
183.61
 Profit(+)/Loss(-) before tax
188.94
169.18
516.07
455.32
608.46
 Provision for taxation
16.87
13.00
34.74
30.00
42.00
 Provision for deferred tax
11.58
32.87
61.24
93.62
127.40
  Net Profit / Loss
160.49
123.31
420.10
331.70
439.06
 Paid up Equity Share Capital
-
-
- -
1095.58
 Reserves excluding revaluation reserves of previous accounting year
-
-
- -
1710.44
 EPS (Rs) : (Not Annulised)

   -Basic

   -Diluted
1.48
1.48
1.16
1.13
3.85
3.85
3.26
3.03
3.84
3.64
Notes:
a) During the quarter under review the turnover of the company has increased by 33.63% and the net profit after tax has increased by 30.15% over the corresponding figures of previous year quarter.
b) In its Board Meeting held on 23rd January, 2003 the Board of Director have re-issued the 175900 forfeited equity shares to the employees of the Company at price of Rs.15/- per shares.
c) The company is exclusively in the pharmaceutical business segment.
d) The previous period figures have been regrouped and rearranged wherever necessary.
e) The above financial results were taken on record by the Board at its meeting held on 31st January, 2003
 For Ind-Swift Laboratories Limited
   
       
   
Sd/-
Sd/-
 
Place:Chandigarh
(N.R.MUNJAL)
(V.K.MEHTA)
 
   
 
Date:30.07.2002
Managing Director
Jt.Managing Director
       

To know about our Formulation Division, please visit us at Ind-Swift Limited, our other group company.